Literature DB >> 11017802

Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever.

C Cazeneuve1, H Ajrapetyan, S Papin, F Roudot-Thoraval, D Geneviève, E Mndjoyan, M Papazian, A Sarkisian, A Babloyan, B Boissier, P Duquesnoy, J C Kouyoumdjian, E Girodon-Boulandet, G Grateau, T Sarkisian, S Amselem.   

Abstract

Familial Mediterranean fever (FMF) is a recessively inherited disorder predisposing to renal amyloidosis and associated with mutations in MEFV, a gene encoding a protein of unknown function. Differences in clinical expression have been attributed to MEFV-allelic heterogeneity, with the M694V/M694V genotype associated with a high prevalence of renal amyloidosis. However, the variable risk for patients with identical MEFV mutations to develop this severe complication, prevented by lifelong administration of colchicine, strongly suggests a role for other genetic and/or environmental factors. To overcome the well-known difficulties in the identification of modifying genetic factors, we investigated a relatively homogeneous population sample consisting of 137 Armenian patients with FMF from 127 independent families living in Armenia. We selected the SAA1, SAA2, and APOE genes-encoding serum amyloid proteins and apolipoprotein E, respectively-as well as the patients' sex, as candidate modifiers for renal amyloidosis. A stepwise logistic-regression analysis showed that the SAA1alpha/alpha genotype was associated with a sevenfold increased risk for renal amyloidosis, compared with other SAA1 genotypes (odds ratio [OR] 6. 9; 95% confidence interval [CI] 2.5-19.0). This association, which was present whatever the MEFV genotype, was extremely marked in patients homozygous for M694V (11/11). The risk for male patients of developing renal amyloidosis was fourfold higher than that for female patients (OR=4.0; 95% CI=1.5-10.8). This association, particularly marked in patients who were not homozygous for M694V (34.0% vs. 11.6%), was independent of SAA1-allelic variations. Polymorphisms in the SAA2 or APOE gene did not appear to influence susceptibility to renal amyloidosis. Overall, these data, which provide new insights into the pathophysiology of FMF, demonstrate that susceptibility to renal amyloidosis in this Mendelian disorder is influenced by at least two MEFV-independent factors of genetic origin-SAA1 and sex-that act independently of each other.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11017802      PMCID: PMC1288556          DOI: 10.1016/S0002-9297(07)62944-9

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  31 in total

Review 1.  Phenotypes of patients with "simple" Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics.

Authors:  K M Dipple; E R McCabe
Journal:  Am J Hum Genet       Date:  2000-05-01       Impact factor: 11.025

2.  Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis.

Authors:  S D Yan; H Zhu; A Zhu; A Golabek; H Du; A Roher; J Yu; C Soto; A M Schmidt; D Stern; M Kindy
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

Review 3.  Amyloids: tombstones or triggers?

Authors:  R Kisilevsky
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

4.  Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis.

Authors:  M Moriguchi; C Terai; Y Koseki; M Uesato; A Nakajima; S Inada; M Nishinarita; S Uchida; A Nakajima; S Y Kim; C L Chen; N Kamatani
Journal:  Hum Genet       Date:  1999-10       Impact factor: 4.132

Review 5.  Familial Mediterranean fever. A survey of 470 cases and review of the literature.

Authors:  E Sohar; J Gafni; M Pras; H Heller
Journal:  Am J Med       Date:  1967-08       Impact factor: 4.965

6.  Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid.

Authors:  T Wisniewski; B Frangione
Journal:  Neurosci Lett       Date:  1992-02-03       Impact factor: 3.046

Review 7.  Familial Mediterranean fever: report of a large family, review of the literature, and discussion of the frequency of amyloidosis.

Authors:  J Meyerhoff
Journal:  Medicine (Baltimore)       Date:  1980-01       Impact factor: 1.889

8.  Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever.

Authors:  D Zemer; M Pras; E Sohar; M Modan; S Cabili; J Gafni
Journal:  N Engl J Med       Date:  1986-04-17       Impact factor: 91.245

9.  Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism.

Authors:  L G Goldfarb; R B Petersen; M Tabaton; P Brown; A C LeBlanc; P Montagna; P Cortelli; J Julien; C Vital; W W Pendelbury
Journal:  Science       Date:  1992-10-30       Impact factor: 47.728

10.  Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation.

Authors:  R L Meek; J S Hoffman; E P Benditt
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  29 in total

1.  New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes.

Authors:  Catherine Dodé; Nathalie Le Dû; Laurence Cuisset; Frank Letourneur; Jean-Marie Berthelot; Gérard Vaudour; Alain Meyrier; Richard A Watts; David G I Scott; Anne Nicholls; Brigitte Granel; Camille Frances; François Garcier; Patrick Edery; Serge Boulinguez; Jean-Paul Domergues; Marc Delpech; Gilles Grateau
Journal:  Am J Hum Genet       Date:  2002-04-25       Impact factor: 11.025

2.  ABCC6 is unlikely to be a modifier gene for familial Mediterranean fever severity.

Authors:  N Chassaing; I Touitou; D Cattan; P Calvas
Journal:  J Genet       Date:  2007-12       Impact factor: 1.166

Review 3.  Recurrent febrile syndromes: what a rheumatologist needs to know.

Authors:  Hal M Hoffman; Anna Simon
Journal:  Nat Rev Rheumatol       Date:  2009-05       Impact factor: 20.543

4.  Modifier variant of METTL13 suppresses human GAB1-associated profound deafness.

Authors:  Rizwan Yousaf; Zubair M Ahmed; Arnaud Pj Giese; Robert J Morell; Ayala Lagziel; Alain Dabdoub; Edward R Wilcox; Sheikh Riazuddin; Thomas B Friedman; Saima Riazuddin
Journal:  J Clin Invest       Date:  2018-03-12       Impact factor: 14.808

5.  Serum amyloid A levels are associated with polymorphic variants in the serum amyloid A 1 and 2 genes.

Authors:  Kayleigh Griffiths; Alexander P Maxwell; Rachel V McCarter; Patrick Nicol; Ruth E Hogg; Mark Harbinson; Gareth J McKay
Journal:  Ir J Med Sci       Date:  2019-03-09       Impact factor: 1.568

Review 6.  Familial Mediterranean fever.

Authors:  Aysin Bakkaloglu
Journal:  Pediatr Nephrol       Date:  2003-06-27       Impact factor: 3.714

7.  A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis.

Authors:  Ayse Cefle; Sevil Kamali; Mehmet Sayarlioglu; Murat Inanc; Lale Ocal; Orhan Aral; Meral Konice; Ahmet Gul
Journal:  Rheumatol Int       Date:  2004-07-30       Impact factor: 2.631

8.  Involvement of the modifier gene of a human Mendelian disorder in a negative selection process.

Authors:  Isabelle Jéru; Hasmik Hayrapetyan; Philippe Duquesnoy; Emmanuelle Cochet; Jean-Louis Serre; Josué Feingold; Gilles Grateau; Tamara Sarkisian; Marc Jeanpierre; Serge Amselem
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

9.  Familial mediterranean Fever: a retrospective clinical and molecular study in the East of anatolia region of Turkey.

Authors:  Ebru Onalan Etem; Ebru Etem; Sukriye Derya Deveci; Deniz Erol; Huseyin Yuce; Halit Elyas
Journal:  Open Rheumatol J       Date:  2010-01-29

10.  Mice with alopecia, osteoporosis, and systemic amyloidosis due to mutation in Zdhhc13, a gene coding for palmitoyl acyltransferase.

Authors:  Amir N Saleem; Yen-Hui Chen; Hwa Jin Baek; Ya-Wen Hsiao; Hong-Wen Huang; Hsiao-Jung Kao; Kai-Ming Liu; Li-Fen Shen; I-Wen Song; Chen-Pei D Tu; Jer-Yuarn Wu; Tateki Kikuchi; Monica J Justice; Jeffrey J Y Yen; Yuan-Tsong Chen
Journal:  PLoS Genet       Date:  2010-06-10       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.